• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测量重组人溶血磷脂酰胆碱酰基转移酶3活性的新型检测方法。

A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.

作者信息

Du Xinming, Hu Jiachun, Zhang Qing, Liu Qi, Xiang Xinxin, Dong Jibin, Lou Bin, He Shuhua, Gu Xiang, Cao Yu, Li Yingxia, Ding Tingbo

机构信息

Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai, China.

Department of Pharmacology and Biochemistry, School of Pharmacy, Fudan University, Shanghai, China.

出版信息

FEBS Open Bio. 2019 Oct;9(10):1734-1743. doi: 10.1002/2211-5463.12712. Epub 2019 Aug 30.

DOI:10.1002/2211-5463.12712
PMID:31376210
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6768109/
Abstract

Lysophosphatidylcholine acyltransferase 3 (LPCAT3) is an important enzyme in phospholipid remodeling, a process that influences the biophysical properties of cell membranes and thus cell function. Multiple lines of evidence suggest that LPCAT3 is involved in several diseases, including atherosclerosis, non-alcoholic steatohepatitis, and carcinoma. Thus, LPCAT3 may have potential as a therapeutic target for these diseases. In the present study, we devised an assay based on reversed-phase HPLC to measure LPCAT3 activity, which may facilitate the identification of LPCAT3 inhibitors and activators. We found that optimal pH and temperature of recombinant human LPCAT3 are 6.0 and 30 °C, respectively. The enzyme K values for substrates NBD-labelled lysophosphatidylcholine and arachidonoyl CoA were 266.84 ± 3.65 and 11.03 ± 0.51 μmol·L , respectively, and the V was 39.76 ± 1.86 pmol·min ·U . Moreover, we used our new method to determine the IC of a known LPCAT inhibitor, TSI-10. In conclusion, this novel assay can be used to measure the effects of compounds on LPCAT3 activity.

摘要

溶血磷脂酰胆碱酰基转移酶3(LPCAT3)是磷脂重塑过程中的一种重要酶,该过程会影响细胞膜的生物物理特性,进而影响细胞功能。多项证据表明,LPCAT3与多种疾病有关,包括动脉粥样硬化、非酒精性脂肪性肝炎和癌症。因此,LPCAT3可能具有作为这些疾病治疗靶点的潜力。在本研究中,我们设计了一种基于反相高效液相色谱的测定方法来测量LPCAT3活性,这可能有助于鉴定LPCAT3抑制剂和激活剂。我们发现重组人LPCAT3的最佳pH值和温度分别为6.0和30℃。底物NBD标记的溶血磷脂酰胆碱和花生四烯酰辅酶A的酶K值分别为266.84±3.65和11.03±0.51μmol·L,V为39.76±1.86 pmol·min·U。此外,我们使用新方法测定了已知LPCAT抑制剂TSI-10的IC。总之,这种新的测定方法可用于测量化合物对LPCAT3活性的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/54f21ac2b863/FEB4-9-1734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/5380f6b52f43/FEB4-9-1734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/e50572e5b578/FEB4-9-1734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/d9b75ad7350d/FEB4-9-1734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/fc89edc33e18/FEB4-9-1734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/54f21ac2b863/FEB4-9-1734-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/5380f6b52f43/FEB4-9-1734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/e50572e5b578/FEB4-9-1734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/d9b75ad7350d/FEB4-9-1734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/fc89edc33e18/FEB4-9-1734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b56/6768109/54f21ac2b863/FEB4-9-1734-g005.jpg

相似文献

1
A novel assay for measuring recombinant human lysophosphatidylcholine acyltransferase 3 activity.一种用于测量重组人溶血磷脂酰胆碱酰基转移酶3活性的新型检测方法。
FEBS Open Bio. 2019 Oct;9(10):1734-1743. doi: 10.1002/2211-5463.12712. Epub 2019 Aug 30.
2
Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎中溶血磷脂酰胆碱酰基转移酶 3 减少导致的肝实质细胞凋亡:非依赖性机制。
J Gastroenterol Hepatol. 2019 Jul;34(7):1256-1262. doi: 10.1111/jgh.14461. Epub 2018 Sep 23.
3
Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.溶血磷脂酰胆碱酰基转移酶3的缺乏通过减少小鼠的脂质吸收来降低血浆脂质水平。
Gastroenterology. 2015 Nov;149(6):1519-29. doi: 10.1053/j.gastro.2015.07.012. Epub 2015 Jul 27.
4
Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.一种主要肝脏溶血磷脂酰胆碱酰基转移酶的鉴定与表征
J Biol Chem. 2008 Mar 28;283(13):8258-65. doi: 10.1074/jbc.M710422200. Epub 2008 Jan 14.
5
Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling.溶血磷脂酰胆碱酰基转移酶的底物偏好突出了其在磷脂重塑中的作用。
Lipids. 2008 Oct;43(10):895-902. doi: 10.1007/s11745-008-3233-y. Epub 2008 Sep 10.
6
Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.鉴定肝溶血磷脂酰胆碱酰基转移酶3为受过氧化物酶体增殖物激活受体δ调控的新靶基因。
J Biol Chem. 2017 Jan 20;292(3):884-897. doi: 10.1074/jbc.M116.743575. Epub 2016 Dec 2.
7
Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.溶血磷脂酰胆碱酰基转移酶 3 敲低介导的肝脏溶血磷脂酰胆碱积累通过增强微粒体甘油三酯转移蛋白表达促进极低密度脂蛋白的产生。
J Biol Chem. 2012 Jun 8;287(24):20122-31. doi: 10.1074/jbc.M111.334664. Epub 2012 Apr 17.
8
Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.溶血磷脂酰胆碱酰基转移酶3依赖性花生四烯酰磷脂的产生是甘油三酯分泌的关键决定因素。
Elife. 2015 Mar 25;4:e06557. doi: 10.7554/eLife.06557.
9
The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3.溶血磷脂酰胆碱酰基转移酶 3 对磷脂酰甘油的结构重塑的基础。
Nat Commun. 2021 Nov 25;12(1):6869. doi: 10.1038/s41467-021-27244-1.
10
Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression.溶血磷脂酰胆碱酰基转移酶-3表达与动脉粥样硬化进展相关。
J Vasc Res. 2017;54(4):200-208. doi: 10.1159/000473879. Epub 2017 Jul 6.

引用本文的文献

1
Circular RNAs in ferroptosis: regulation mechanism and potential clinical application in disease.铁死亡中的环状RNA:调控机制及其在疾病中的潜在临床应用
Front Pharmacol. 2023 Jun 2;14:1173040. doi: 10.3389/fphar.2023.1173040. eCollection 2023.
2
Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation.Lpcat3 缺乏通过增强 ROS 生成促进棕榈酸诱导的 3T3-L1 成熟脂肪细胞炎症。
Acta Biochim Biophys Sin (Shanghai). 2022 Nov 25;55(1):117-130. doi: 10.3724/abbs.2022161.

本文引用的文献

1
Macrophage Lysophosphatidylcholine Acyltransferase 3 Deficiency-Mediated Inflammation Is Not Sufficient to Induce Atherosclerosis in a Mouse Model.巨噬细胞溶血磷脂酰胆碱酰基转移酶3缺乏介导的炎症不足以在小鼠模型中诱发动脉粥样硬化。
Front Cardiovasc Med. 2019 Jan 17;5:192. doi: 10.3389/fcvm.2018.00192. eCollection 2018.
2
Phospholipid Remodeling in Physiology and Disease.磷脂代谢重编程在生理和疾病中的作用
Annu Rev Physiol. 2019 Feb 10;81:165-188. doi: 10.1146/annurev-physiol-020518-114444. Epub 2018 Oct 31.
3
Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.
非酒精性脂肪性肝炎中溶血磷脂酰胆碱酰基转移酶 3 减少导致的肝实质细胞凋亡:非依赖性机制。
J Gastroenterol Hepatol. 2019 Jul;34(7):1256-1262. doi: 10.1111/jgh.14461. Epub 2018 Sep 23.
4
LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.造血细胞中 LPCAT3 的缺乏会改变胆固醇和磷脂的动态平衡,促进动脉粥样硬化。
Atherosclerosis. 2018 Aug;275:409-418. doi: 10.1016/j.atherosclerosis.2018.05.023. Epub 2018 May 18.
5
Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway.溶血磷脂酰胆碱酰基转移酶 3 缺乏通过激活 Wnt/β-连环蛋白通路损害 3T3L1 细胞脂肪生成。
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Aug;1863(8):834-843. doi: 10.1016/j.bbalip.2018.04.008. Epub 2018 Apr 17.
6
Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis.磷脂重塑和胆固醇可用性调节肠道干性和肿瘤发生。
Cell Stem Cell. 2018 Feb 1;22(2):206-220.e4. doi: 10.1016/j.stem.2017.12.017.
7
Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression.溶血磷脂酰胆碱酰基转移酶-3表达与动脉粥样硬化进展相关。
J Vasc Res. 2017;54(4):200-208. doi: 10.1159/000473879. Epub 2017 Jul 6.
8
Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.鉴定肝溶血磷脂酰胆碱酰基转移酶3为受过氧化物酶体增殖物激活受体δ调控的新靶基因。
J Biol Chem. 2017 Jan 20;292(3):884-897. doi: 10.1074/jbc.M116.743575. Epub 2016 Dec 2.
9
Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism.小肠而非肝脏溶血磷脂酰胆碱酰基转移酶3(Lpcat3)缺乏对血浆脂质代谢具有显著影响。
J Biol Chem. 2016 Apr 1;291(14):7651-60. doi: 10.1074/jbc.M115.697011. Epub 2016 Jan 31.
10
Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.溶血磷脂酰胆碱酰基转移酶3的缺乏通过减少小鼠的脂质吸收来降低血浆脂质水平。
Gastroenterology. 2015 Nov;149(6):1519-29. doi: 10.1053/j.gastro.2015.07.012. Epub 2015 Jul 27.